Noscapine-bile acid hybrids as novel anticancer agents

Abstract

Twenty novel noscapinoid–triterpene conjugate derivatives were designed and synthesized. Four noscapine derivatives (as secondary amine) and five bile acids were applied for the synthesis of a diverse library. The synthetic compounds were evaluated for their antiproliferative activity against PC3, A549, HepG2, Caki-1, U138MG, and MRC5. This study identified eight potent cytotoxic agents (7e–7i, 7k, 7m, and 7o) possessing more than 80% cell viability. Compounds 7e and 7f exhibited the highest cytotoxic activity against Caki-1 with IC50 values of 260 nM and 350 nM, respectively. Western blot analysis results indicated that the eight hit compounds decreased the α-tubulin and β-actin levels in A549 cells, and further cellular assays on A549 demonstrated that 7e and 7f significantly inhibited cell migration, induced pronounced G1 cell-cycle arrest (with 7f also showing a minor G2/M increase) and triggered marked apoptosis, with 7e showing the strongest pro-apoptotic effect.

Graphical abstract: Noscapine-bile acid hybrids as novel anticancer agents

Supplementary files

Article information

Article type
Research Article
Submitted
29 Jun 2025
Accepted
23 Aug 2025
First published
29 Aug 2025

RSC Med. Chem., 2025, Advance Article

Noscapine-bile acid hybrids as novel anticancer agents

K. Babanezhad Harikandei, P. Salehi, Z. Hasanpour, M. Bararjanian, W. Kim, S. M. Asghari and A. Mardinoglu, RSC Med. Chem., 2025, Advance Article , DOI: 10.1039/D5MD00570A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements